Colgate-Palmolive announced its Q4 and full year 2021 results, with Q4 net sales increasing by 2.0% and organic sales increasing by 3.0%. EPS declined by 76% to $0.18, influenced by goodwill and intangible asset impairment charges related to the Filorga skin health business. The company's leadership in toothpaste and manual toothbrushes continued, with global market shares of 39.4% and 30.9% respectively.
Net sales increased by 2.0% with organic sales up by 3.0% for Q4 2021.
EPS decreased by 76% to $0.18 due to impairment charges related to the Filorga business.
Base Business EPS grew 3% to $0.79.
Gross profit margin decreased to 58.1%.
The Company expects net sales growth to be 1% to 4% including a low-single-digit negative impact from foreign exchange. The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%. On a GAAP basis, the Company expects gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth. On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion, increased advertising investment and low to mid-single-digit earnings-per-share growth.
Visualization of income flow from segment revenue to net income